SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $390,997 | -10.0% | 14,182 | -1.8% | 0.02% | 0.0% |
| Q2 2023 | $434,246 | -17.0% | 14,446 | 0.0% | 0.02% | -21.9% |
| Q1 2023 | $523,378 | +97545.1% | 14,446 | -3.9% | 0.03% | -3.0% |
| Q4 2022 | $536 | -99.9% | 15,026 | -8.4% | 0.03% | -8.3% |
| Q3 2022 | $555,000 | +12.6% | 16,396 | -3.7% | 0.04% | +20.0% |
| Q2 2022 | $493,000 | -6.8% | 17,033 | +4.0% | 0.03% | +11.1% |
| Q1 2022 | $529,000 | -18.2% | 16,371 | -26.2% | 0.03% | -12.9% |
| Q4 2021 | $647,000 | +1.3% | 22,176 | -7.4% | 0.03% | -3.1% |
| Q3 2021 | $639,000 | +5.6% | 23,954 | +3.7% | 0.03% | 0.0% |
| Q2 2021 | $605,000 | 0.0% | 23,103 | 0.0% | 0.03% | 0.0% |
| Q1 2021 | $605,000 | – | 23,103 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |